Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, Saucedo J, Scheller B, Kleber FX; International DCB Consensus Group.
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27.
Clinical Utility of Intravascular Imaging: Past, Present, and Future.
Mintz GS, Matsumura M, Ali Z, Maehara A.
JACC Cardiovasc Imaging. 2022 Oct;15(10):1799-1820. doi: 10.1016/j.jcmg.2022.04.026. Epub 2022 Sep 14.
Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation.
Hong SJ, Kim H, Ahn CM, Kim JS, Kim BK, Ko YG, Hong BK, Choi D, Jang Y, Hong MK.
Yonsei Med J. 2019 Sep;60(9):824-831. doi: 10.3349/ymj.2019.60.9.824.
Bioresorbable Vascular Scaffold Compared With Minimally Invasive Bypass Surgery for the Left Anterior Descending Coronary Artery Disease: 12-Month Follow up.
Vakkosov KM, Kochergin NA, Kozyrin KA, Ganjukov VI.
Kardiologiia. 2018 Dec 25;58(12):30-35. doi: 10.18087/cardio.2018.12.10165.
Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis?
Levent F, Senoz O, Emren SV, Emren ZY, Gediz RB.
Herz. 2022 Feb;47(1):73-78. doi: 10.1007/s00059-021-05036-z. Epub 2021 Apr 24.
Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.
Li Y, Hou X, Liu T, Xu S, Huang Z, Xu X, Dong R.
Front Cardiovasc Med. 2022 Apr 1;9:802181. doi: 10.3389/fcvm.2022.802181. eCollection 2022.
Percutaneous coronary intervention to treat unprotected left main: Common (un-answered) challenges.
Kovacevic M, Burzotta F, Srdanovic I, Petrovic M, Trani C.
Kardiol Pol. 2022;80(4):417-428. doi: 10.33963/KP.a2022.0078.
Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
Valgimigli M, Wlodarczak A, Tölg R, Merkely B, Kelbæk H, Legutko J, Galli S, Godin M, Toth GG, Lhermusier T, Honton B, Dietrich PL, Stammen F, Ferdinande B, Silvain J, Capodanno D, Cayla G; Bioflow-DAPT Investigators.
Circulation. 2023 Sep 26;148(13):989-999. doi: 10.1161/CIRCULATIONAHA.123.065448. Epub 2023 Aug 25.
The impact of new generation drug-eluting stent implantation on patients with chronic kidney disease and a single lesion in the proximal segment of the left anterior descending artery.
Toutouzas K, Patsa C, Synetos A, Karanasos A, Karampelas J, Tsiamis E, Spanos A, Stefanadi E, Tousoulis D, Stefanadis C.
Hellenic J Cardiol. 2011 Mar-Apr;52(2):103-10.
Single versus double stenting for unprotected left main coronary artery bifurcation lesions: a systematic review and meta-analysis.
Karrowni W, Makki N, Dhaliwal AS, Vyas A, Blevins A, Dughman S, Girotra S, Cram P, Horwitz PA.
J Invasive Cardiol. 2014 Jun;26(6):229-33.
